Mohammed Ferdaus was awarded a Ph.D. by Shimane University School of Medicine, Izumo, Japan in July 2014. His Ph.D. work focused on the role of sympathetic nervous system hyperactivity, which has been implicated in the pathogenesis of essential hypertension. As Mohammed's interest is in the field of hypertension, and the kidney plays a key role in blood pressure regulation, he decided to join Dr. McCormick's lab as a Postdoctoral Researcher in August 2014.
His current work focuses on the regulation of renal sodium and potassium transport by the WNK-SPAK/OSR1 Kinase signaling pathway. Mohammed is currently funded by an American Heart Association (AHA) Postdoctoral Fellowship to investigate the role of mutations in Cullin-3, a key regulator of WNK kinases, in the pathogenesis of Familial Hyperkalemic hypertension (FHHt).
Mohammed researches the role of mutations in Cullin-3, a key regulator of WNK kinases, in the pathogenesis of Familial Hyperkalemic hypertension (FHHt).